Gilead Sciences, Inc.: Gilead Presents Real-World and Long-Term Data From HIV Research Programs at HIV Glasgow 2022
- New Clinical and Patient-Reported Outcomes in People with HIV on Biktarvy in Observational BICSTaR Study Demonstrate Consistent Efficacy Profile in Real-World Setting - - Long-Term Switch Data